Persistent or Long-standing Persistent Atrial Fibrillation
Investigational drug(s) / intervention(s)
Control interventionExperimental intervention
Control intervention: patients treated with balloon-based ablation of AF by PVI
Experimental intervention: patients treated with balloon-based ablation of AF by PVI
Study summary
Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial fibrillation can reduce atrial fibrillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Persistent or long-standing persistent AF (i.e. continuous AF that was/is sustained \>7 days or \>12 months, respectively)
2. Age ≥18 and ≤80 years
3. Indication for AF ablation as per current guidelines
Exclusion Criteria:
1. Missing informed consent
2. LAA diameter \>25mm 10mm distant from circumflex artery assessed by TEE
3. Paroxysmal atrial fibrillation
4. Long-standing persistent atrial fibrillation with a continuous AF duration of \>4 years
5. Previous pulmonary vein isolation or MAZE surgery
6. Previous led atrial appendage closure or surgical excision
7. Left atrial diameter \>60 mm at baseline
8. Left atrial thrombus at baseline
Primary outcome measure(s)
Time until any documented episode of ATa — 3 - 12 months Time until any documented episode of atrial tachyarrhythmia (ATa: atrial fibrillation or atrial tachycardia) lasting longer than 30 seconds within 3-12 months after index ablation without antiarrhythmic therapy
Trial sites (3)
Facility
City
Region
Status
University Hospital Eppendorf, Hamburg, Germany
Hamburg
Free and Hanseatic City of Hamburg
Recruiting
Asklepios Klinik Altona
Hamburg
Free and Hanseatic City of Hamburg
Recruiting
Clinic for Rhythmologiy Luebeck, Schleswig-Holstein Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.